difference between semaglutide and glp 1 vs Tirzepatide… which one actually wins? 👀 Both are FDA-approved. Both help with weight loss. But they don't hit your body the same way… Semaglutide • Targets GLP-1 • Cuts cravings + Semaglutide GLP-1 Treatment Specialist |

Jensen SBK, Blond MB, Sandsdal RM, et al

Food and Drug Administration first approved semaglutide as Ozempic for type 2 diabetes in 2017 and as Wegovy for chronic weight management in 2021, and approved tirzepatide as Mounjaro for type 2 diabetes in 2022 and as Zepbound for chronic weight management in 2023

They can be especially helpful because they reduce decision fatigue, lower waste, and make it easier to keep small, protein-aware meals ready ahead of time

Taking your dose early every week effectively shortens your injection interval from seven days to six days or less, which increases your total cumulative dose over time